Pulmonx Corp (NASDAQ: LUNG) on Friday, soared 8.88% from the previous trading day, before settling in for the closing price of $1.69. Within the past 52 weeks, LUNG’s price has moved between $1.47 and $9.37.
Annual sales at Healthcare sector company slipped by -19.80% over the past five years. The company achieved an average annual earnings per share of -7.46%. With a float of $36.05 million, this company’s outstanding shares have now reached $40.74 million.
Pulmonx Corp (LUNG) Insider and Institutional Ownership
Observing investor behavior towards Medical Devices industry stocks is more important than anything else. The insider ownership of Pulmonx Corp is 11.54%, while institutional ownership is 84.57%. The most recent insider transaction that took place on Sep 02 ’25, was worth 15,437. In this transaction PRESIDENT AND CEO of this company sold 9,648 shares at a rate of $1.60, taking the stock ownership to the 358,967 shares. Before that another transaction happened on Sep 02 ’25, when Company’s Chief Financial Officer & PAO sold 7,936 for $1.60, making the entire transaction worth $12,698. This insider now owns 208,489 shares in total.
Pulmonx Corp (LUNG) Latest Financial update
As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.36 earnings per share (EPS) for the period topping the consensus outlook (set at -0.44) by 0.08. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.39 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -7.46% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 16.00% during the next five years compared to -19.80% drop over the previous five years of trading.
Pulmonx Corp (NASDAQ: LUNG) Trading Performance Indicators
Pulmonx Corp (LUNG) is currently performing well based on its current performance indicators. A quick ratio of 4.62 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.83.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.43, a number that is poised to hit -0.42 in the next quarter and is forecasted to reach -1.33 in one year’s time.
Technical Analysis of Pulmonx Corp (LUNG)
Pulmonx Corp (NASDAQ: LUNG) saw its 5-day average volume 0.32 million, a negative change from its year-to-date volume of 0.45 million. As of the previous 9 days, the stock’s Stochastic %D was 37.97%.
During the past 100 days, Pulmonx Corp’s (LUNG) raw stochastic average was set at 15.35%, which indicates a significant decrease from 71.51% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1063 in the past 14 days, which was lower than the 0.1971 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.7836, while its 200-day Moving Average is $4.3922. Nevertheless, the first resistance level for the watch stands at $1.9600 in the near term. At $2.0800, the stock is likely to face the second major resistance level. The third major resistance level sits at $2.2200. If the price goes on to break the first support level at $1.7000, it is likely to go to the next support level at $1.5600. The third support level lies at $1.4400 if the price breaches the second support level.
Pulmonx Corp (NASDAQ: LUNG) Key Stats
Market capitalization of the company is 74.97 million based on 40,747K outstanding shares. Right now, sales total 83,790 K and income totals -56,390 K. The company made 23,860 K in profit during its latest quarter, and -15,170 K in sales during its previous quarter.
